Biotech IPO Calendar
The BioPharmCatalyst Biotech Stock IPO Calendar gives a brief rundown of upcoming biotech initial public offerings.
The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months.
As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. Conversely, it is not uncommon to see stocks also lose over half their value.
Filter by offer date, IPO price and return to date.
As of mid-September, 2017, 37 of the 62 (60%) of Healthcare IPOs since 2016 have exhibited a positive return.
10 IPOs have shown returns of over 100% while FIVE have seen the value of their company fall by over half.
For a full list of over 400 biotech and pharma companies listed on BioPharmCatalyst we suggest you visit the Biotech Stocks page to search for your ticker of choice.
Upcoming catalysts that are often responsible for the high volatility in such stocks can be found in the BioPharmCatalyst FDA Calendar.
Data generously supplied by IPOScoop.com
| Ticker | Company | Company lead managers | Shares | Estimated volume | Expected trade date |
|---|---|---|---|---|---|
| CELC | Celcuity | Craig-Hallum Capital Group | 2 Million | 18 Million | |
| KRYS | Krystal Biotech | Ladenburg Thalmann | 3 Million | 30 Million | |
| ZLAB | Zai Lab Ltd. | J.P. Morgan/ Citigroup/ Leerink Partners | 5.88 Million | 100 Million | |
| DCPH | Deciphera Pharmaceuticals | J.P. Morgan/ Piper Jaffray | 6.25 Million | 100 Million | |
| NCNA | NuCana plc | Citigroup/ Jefferies/ Cowen | 6.67 Million | 100.01 Million |
Historical IPO Database
Last 64 IPO's
| index | Ticker | Company | IPO price | Price after first day | Current price | Return | Offer date |
|---|---|---|---|---|---|---|---|
| 1 | ZEAL | Zealand Pharma A/S | $17.87 | $17.82 | $17.90 | 0.17% | 08/09/2017 |
| 2 | CMTA | Clementia Pharmaceuticals | $15.00 | $16.35 | $16.61 | 10.73% | 08/02/2017 |
| 3 | SNNA | Sienna Biopharmaceuticals | $15.00 | $19.25 | $22.23 | 48.20% | 07/27/2017 |
| 4 | PETQ | PetIQ | $16.00 | $23.32 | $23.26 | 45.38% | 07/21/2017 |
| 5 | KALA | Kala Pharmaceuticals | $15.00 | $18.49 | $21.99 | 46.60% | 07/20/2017 |
| 6 | AKCA | Akcea Therapeutics | $8.00 | $9.48 | $24.00 | 200.00% | 07/14/2017 |
| 7 | CODX | Co-Diagnostics | $6.00 | $5.81 | $5.45 | -9.17% | 07/12/2017 |
| 8 | ALRN | Aileron Therapeutics | $15.00 | $10.80 | $11.59 | -22.73% | 06/29/2017 |
| 9 | DOVA | Dova Pharmaceuticals | $17.00 | $19.81 | $26.16 | 53.88% | 06/29/2017 |
| 10 | MRSN | Mersana Therapeutics | $15.00 | $14.00 | $15.92 | 6.13% | 06/28/2017 |
| 11 | ATXI | Avenue Therapeutics | $6.00 | $8.25 | $5.55 | -7.50% | 06/27/2017 |
| 12 | ATNX | Athenex | $11.00 | $12.56 | $17.03 | 54.82% | 06/14/2017 |
| 13 | IMRN | Immuron Ltd (stock) | $9.99 | N/A | $5.75 | -42.44% | 06/09/2017 |
| 14 | IMRNW | Immuron Ltd (warrants) | N/A | N/A | $0.90 | 0.00% | 06/09/2017 |
| 15 | ARGX | argenx SE | $17.00 | $23.00 | $23.00 | 35.29% | 05/18/2017 |
| 16 | GTHX | G1 Therapeutics | $15.00 | $15.00 | $24.77 | 65.13% | 05/17/2017 |
| 17 | OVID | Ovid Therapeutics | $15.00 | $12.25 | $9.26 | -38.27% | 05/05/2017 |
| 18 | BHVN | Biohaven Pharmaceutical Holding | $17.00 | $17.50 | $37.35 | 119.71% | 05/04/2017 |
| 19 | BOLT | BioLight Life Sciences Ltd. | N/A | N/A | N/A | 0.00% | 05/04/2017 |
| 20 | URGN | UroGen Pharma Ltd. | $13.00 | $13.98 | $32.13 | 147.15% | 05/04/2017 |
| 21 | ZYME | Zymeworks | $13.00 | $13.00 | $7.93 | -39.00% | 04/28/2017 |
| 22 | VRNA | Verona Pharma plc | $13.50 | $13.50 | $13.50 | 0.00% | 04/27/2017 |
| 23 | TOCA | Tocagen | $10.00 | $12.45 | $13.10 | 31.00% | 04/13/2017 |
| 24 | VLRX | Valeritas Holdings | $10.00 | $7.12 | $7.12 | -28.80% | 03/23/2017 |
| 25 | BYSI | BeyondSpring | $20.00 | $16.80 | $38.11 | 90.55% | 03/09/2017 |
| 26 | JNCE | Jounce Therapeutics | $16.00 | $17.25 | $15.40 | -3.75% | 01/27/2017 |
| 27 | ANAB | AnaptysBio | $15.00 | $17.00 | $35.80 | 138.67% | 01/26/2017 |
| 28 | OBSV | ObsEva SA | $15.00 | $11.65 | $7.27 | -51.53% | 01/26/2017 |
| 29 | MYOV | Myovant Sciences Ltd. | $15.00 | $13.26 | $13.14 | -12.40% | 10/27/2016 |
| 30 | RARX | Ra Pharmaceuticals | $13.00 | $13.00 | $15.44 | 18.77% | 10/26/2016 |
| 31 | IRTC | iRhythm Technologies | $17.00 | $26.05 | $48.80 | 187.06% | 10/20/2016 |
| 32 | CRSP | CRISPR Therapeutics AG | $14.00 | $14.00 | $19.07 | 36.21% | 10/19/2016 |
| 33 | AZRX | AzurRx BioPharma | $5.50 | $4.98 | $4.30 | -21.82% | 10/11/2016 |
| 34 | OBLN | Obalon Therapeutics | $15.00 | $15.00 | $9.99 | -33.40% | 10/06/2016 |
| 35 | FLGT | Fulgent Genetics | $9.00 | $9.18 | $4.96 | -44.89% | 09/29/2016 |
| 36 | ACIU | AC Immune SA | $11.00 | $15.66 | $11.20 | 1.82% | 09/23/2016 |
| 37 | NOVN | Novan | $11.00 | $18.10 | $6.11 | -44.45% | 09/21/2016 |
| 38 | MEDP | Medpace Holdings | $23.00 | $27.79 | $31.26 | 35.91% | 08/11/2016 |
| 39 | PTGX | Protagonist Therapeutics | $12.00 | $11.70 | $16.54 | 37.83% | 08/11/2016 |
| 40 | GEMP | Gemphire Therapeutics | $10.00 | $9.20 | $9.11 | -8.90% | 08/05/2016 |
| 41 | TCMD | Tactile Systems Technology | $10.00 | $11.08 | $34.30 | 243.00% | 07/28/2016 |
| 42 | KDMN | Kadmon Holdings | $12.00 | $9.70 | $2.98 | -75.17% | 07/26/2016 |
| 43 | PTHN | Patheon N.V. | $21.00 | $24.99 | $34.98 | 66.57% | 07/21/2016 |
| 44 | BOLD | Audentes Therapeutics | $15.00 | $15.13 | $25.75 | 71.67% | 07/20/2016 |
| 45 | SYRS | Syros Pharmaceuticals | $12.50 | $18.15 | $17.17 | 37.36% | 06/30/2016 |
| 46 | SELB | Selecta Biosciences | $14.00 | $14.00 | $18.62 | 33.00% | 06/22/2016 |
| 47 | CLSD | Clearside Biomedical | $7.00 | $7.25 | $7.60 | 8.57% | 06/02/2016 |
| 48 | RETA | Reata Pharmaceuticals | $11.00 | $13.70 | $31.88 | 189.82% | 05/26/2016 |
| 49 | MRUS | Merus B.V. | $10.00 | $10.04 | $16.20 | 62.00% | 05/19/2016 |
| 50 | PZRX | PhaseRx | $5.00 | $5.02 | $0.72 | -85.60% | 05/18/2016 |
| 51 | ONSIU | Oncobiologics | $6.00 | $4.80 | $4.62 | -23.00% | 05/13/2016 |
| 52 | NTLA | Intellia Therapeutics | $18.00 | $22.10 | $22.81 | 26.72% | 05/06/2016 |
| 53 | SBPH | Spring Bank Pharmaceuticals | $12.00 | $11.10 | $15.44 | 28.67% | 05/06/2016 |
| 54 | ARA | American Renal Associates Holdings | $22.00 | $26.50 | $14.97 | -31.95% | 04/21/2016 |
| 55 | AGLE | Aeglea BioTherapeutics | $10.00 | $9.77 | $4.63 | -53.70% | 04/07/2016 |
| 56 | CRVS | Corvus Pharmaceuticals | $15.00 | $14.25 | $17.23 | 14.87% | 03/23/2016 |
| 57 | SNDX | Syndax Pharmaceuticals | $12.00 | $12.01 | $11.85 | -1.25% | 03/03/2016 |
| 58 | AVXS | AveXis | $20.00 | $18.05 | $91.60 | 358.00% | 02/11/2016 |
| 59 | PTI | Proteostasis Therapeutics | $8.00 | $6.64 | $1.87 | -76.63% | 02/11/2016 |
| 60 | BGNE | BeiGene, Ltd. | $24.00 | $28.32 | $82.77 | 244.88% | 02/03/2016 |
| 61 | EDIT | Editas Medicine | $16.00 | $18.20 | $21.37 | 33.56% | 02/03/2016 |
| 62 | AXSM | Axsome Therapeutics | $9.00 | $8.74 | $5.10 | -43.33% | 11/19/2015 |
| 63 | AAAP | Advanced Accelerator Applications S.A. | $16.00 | $24.50 | $57.63 | 260.19% | 11/11/2015 |
| 64 | GI | EndoChoice Holdings (ECPM Holdings) | $15.00 | $17.00 | $8.00 | -46.67% | 06/05/2015 |